CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 71,000 shares at $1.40 ($99,400)
- 4 Open-market buy Director bought 71,000 shares at $1.40 ($99,400)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy CEO & President bought 12,000 shares at $1.30 ($15,600)
- 4 Open-market buy Director bought 12,500 shares at $1.20 ($15,000)
- 4 Open-market buy Director bought 1,500,000 shares at $1.20 ($1,800,000)
- 4 Open-market buy Director bought 1,500,000 shares at $1.20 ($1,800,000)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 4 Other disposition 10% owner disposed of 2,489,682 shares (other)
- 4 Other acquisition Director acquired 22,461 shares (other)
- 8-K Event Regulation FD disclosure
Page 10 of 16 · 303 filings